Disclosed are methods for reducing the degree of antigen induced inflammation in a sensitized mammals. The disclosed methods employ oligosaccharide glycosides related to blood group determinants having a type I or type II core structure wherein the administration of such oligosaccharide glycosides is after initiation of the mammal's immune response but at or prior one-half the period of time required to effect maximal antigen-induced inflammation.
本发明揭示了一种减少致敏哺乳动物抗原诱导炎症程度的方法。所揭示的方法采用与血型决定因子相关的
寡糖糖苷,其具有I型或II型核心结构,其中
寡糖糖苷的给药是在哺乳动物免疫反应开始后进行的,但在达到最大抗原诱导炎症所需时间的一半或之前进行的。